Skip to main content

Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disease

Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders

  • 1st Edition - October 1, 2024
  • Editors: Valentina Rapozzi, Luigi Xodo, Benjamin Bonavida
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 4 4 3 - 2 2 3 5 4 - 9
  • eBook ISBN:
    9 7 8 - 0 - 4 4 3 - 2 2 3 5 5 - 6

Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Diseases: Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Infla… Read more

Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Disease

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Therapeutic Applications of Nitric Oxide in Cancer and Inflammatory Diseases: Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders presents updated information on the chemistry, signaling of newly derived therapeutic nitric oxide donors/inhibitors, and their complexes in liposomes or nanospheres in both pre-clinical and clinical activities.

In six parts It discusses many examples of research related to the application of novel therapeutic compounds that focus on a chemical, nitric oxide, and their applications that have been shown to exert significant therapeutic activities against various resistant cancers unresponsive to current treatments, and different inflammatory diseases which continue to require novel treatments.

It is a valuable resource for cancer researchers, oncologists, graduate students, and researchers from medical and biomedical fields who want to know more about NO and its therapeutic applications in cancer and inflammatory diseases. It is highly useful for both scientists and clinicians as well as pharmaceutical companies involved in the development of new anticancer/anti-inflammatory agents.